Which has grown faster, BDMD or NEPH?

Over the past five years, NEPH grew revenue faster — BDMD at a 4.46% CAGR versus NEPH at 16.99%.

Is BDMD or NEPH more profitable?

NEPH runs the higher net margin — BDMD at -121.04% versus NEPH at 8.38%.

Baird Medical Investment Holdings Limited (BDMD) vs Nephros, Inc. (NEPH)

A side-by-side comparison of Baird Medical Investment Holdings Limited and Nephros, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BDMD

Baird Medical Investment Holdings Limited

$33M

$0.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

NEPH

Nephros, Inc.

$33M

$3.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BDMD vs NEPH

growth of $100 · dividends reinvested · last 5y

BDMD -92.3% (-40.1%/yr)NEPH -49.4% (-12.7%/yr)NEPH compounded faster over this window

Log scale — wide-divergence pair

BDMD NEPH

BDMD vs NEPH: by the numbers

•BDMD is the larger company ($33M vs $33M market cap).
•NEPH is profitable (8.38% net margin) while BDMD runs a net loss (-121.04%).
•NEPH grew revenue faster over the past five years (16.99% vs 4.46% CAGR).

Metrics side by side

Valuation

Metric	BDMD	NEPH
P/E ratio	N/A	19.03
Forward P/E	9.75	19.28
P/S ratio	N/A	1.58
P/B ratio	0.95	2.74
EV / EBITDA	N/A	16.41

Profitability

Metric	BDMD	NEPH
Gross margin	83.79%	60.31%
Operating margin	-113.31%	7.92%
Net margin	-121.04%	8.38%
ROE	-86.96%	14.51%
ROIC	-50.66%	12.67%

Growth (annualized)

Metric	BDMD	NEPH
Revenue CAGR (5Y)	4.46%	16.99%
Total return CAGR (5Y)	N/A	-15.93%

Frequently asked

Which has grown faster, BDMD or NEPH?: Over the past five years, NEPH grew revenue faster — BDMD at a 4.46% CAGR versus NEPH at 16.99%.
Is BDMD or NEPH more profitable?: NEPH runs the higher net margin — BDMD at -121.04% versus NEPH at 8.38%.

Go deeper

Full BDMD analysis Full NEPH analysis Interactive comparison tool

Dig into the metrics

Nephros P/E ratio Baird Medical Investment ROE Nephros ROE Baird Medical Investment operating margin Nephros operating margin Baird Medical Investment revenue growth Nephros revenue growth Baird Medical Investment free cash flow Nephros free cash flow

Baird Medical Investment & Nephros appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.